Percutaneous Lung Biopsy Using Cone Beam CT With Virtual Guidance: a Randomized Control Trial

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

November 22, 2021

Study Completion Date

November 22, 2021

Conditions
Lung Cancer
Interventions
PROCEDURE

Percutaneous lung biopsy using conventional MDCT

Conventional CT biopsy will be performed using a 64 slice CT scanner. A preliminary plain CT is acquired covering the entire target lesion with a skin marker, and the interventional radiologist would decide on the skin puncture site and the needle pathway. A post-procedural CT scan will be made to detect pneumothorax or pulmonary haemorrhage. All images will be archived in the picture achieving and communication system (PACS).

PROCEDURE

Percutaneous lung biopsy CBCT

CBCT guided biopsy will be performed in the angiography suite. A preliminary CBCT (DynaCT) is acquired covering the entire target lesion is first performed. Image data will be displayed and processed using Syngo iGuide system. A potential needle trajectory will be drawn from skin to lesion. Integration of the cross-sectional images and real time fluoroscopy will result in three system positions: one bull's eye view and two progression views. During fluoroscopy, the planned needle trajectory and target will be overlaid on the real time fluoroscopy image. After the needle reaches the target, another CBCT will be performed to confirm needle position. Biopsy using coaxial system and post-procedural CT scans will be performed in similar fashion as the conventional CT group.

Trial Locations (1)

Unknown

Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT04299542 - Percutaneous Lung Biopsy Using Cone Beam CT With Virtual Guidance: a Randomized Control Trial | Biotech Hunter | Biotech Hunter